Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-02-20 @ 10:45 PM
Study NCT ID:
NCT03130959
Status:
COMPLETED
Last Update Posted:
2022-08-09
First Post:
2017-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-05
First Submit QC Date:
None
Study First Post Date:
2017-04-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-03
Results First Submit QC Date:
None
Results First Post Date:
2021-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-14
Last Update Post Date:
2022-08-09
Last Update Post Date Type:
ACTUAL